Endothelial progenitor cells (EPCs) and endothelial cells (ECs) play a vital role in endothelialization and vascularization for tissue regeneration. Various EPC/EC targeting biomolecules have been investigated to improve tissue regeneration with limited success often due to their limited functional specificity and structural stability. One-Bead-One-Compound (OBOC) combinatorial technology is an ultra-high throughput chemical library synthesis and screening method suitable for ligand discovery against a wide range of biological targets, such as integrins. In this study, using primary human EPCs/ECs as living probes, we identified an αvβ3 integrin ligand LXW7 discovered by OBOC combinatorial technology as a potent and specific EPC/EC targeting ligand. LXW7 overcomes the major barriers of other functional biomolecules that have previously been used to improve vascularization for tissue regeneration, and possesses optimal stability, EPC/EC specificity and functionality. LXW7 is an octamer disulfide cyclic peptide (cGRGDdvc) containing unnatural amino acids flanking both sides of the main functional motif, therefore it will be more resistant to proteolysis and more stable in vivo compared to linear peptides and peptides consisting of only natural amino acids. Compared with the conventional αvβ3 integrin ligand GRGD peptide, LXW7 showed stronger binding affinity to primary EPCs/ECs, but weaker binding to platelets and no binding to THP-1 monocytes. In addition, ECs bound to LXW7 treated culture surface exhibited enhanced biological functions such as proliferation, likely due to increased phosphorylation of VEGF receptor 2 (VEGF-R2) and activation of mitogen-activated protein kinase (MAPK) ERK1/2. Surface modification of electrospun microfibrous PLLA/PCL biomaterial scaffolds with LXW7 via Click chemistry resulted in significantly improved endothelial coverage. LXW7 and its derivatives hold great promise for EPC/EC recruitment and delivery and can be widely applied to functionalize various biological and medical materials to improve endothelialization and vascularization for tissue regeneration applications.
INTRODUCTION
During the last decades, tissue engineering has made considerable progress in the development of tissue substitutes and transplantable organs that maintain, restore, or improve host tissue functions 1 . The potential impact of tissue engineering for changing human healthcare in the future is enormous 2 . Endothelial progenitor cells (EPCs) and endothelial cells (ECs) play a vital role in vascularizing tissue engineered constructs for neotissue formation, long-term survival and function 3, 4 . However, sufficient vascularization has been identified as a major challenge and a limiting factor for successful translation of tissue engineered products 5 .
Bioactive motifs on native extracellular matrices (ECM) are critical in providing cell-binding sites for cell and tissue adhesion, growth and function 6, 7 . Biomaterial-based scaffolds are widely used in tissue engineering applications to provide a structural support for cells, either transplanted or recruited in situ, to attach, proliferate and form new vascular network 8, 9 .
Synthetic materials can be precisely designed to mimic the physical structure of ECM via various sophisticated bioengineering approaches, but their applications are limited due to the lack of bioactive motifs that are present on native ECM. Creating a functional bioactive interface on the synthetic material to mimic native ECM surface could significantly improve the biological functions of artificial scaffolds [10] [11] [12] . Various functional biomolecules and strategies have been used to modify biomaterial-based scaffolds to improve endothelialization and vascularization in the scaffolds 4, [13] [14] [15] [16] [17] [18] . However, most of these biomolecules are limited in translational application due to their unstable structure, non-specific cell-binding affinity, and the lack of the ability to functionally interact with ECs. Therefore, a potent, stable, bioactive molecule that can interact specially with EPCs/ECs but not with other undesirable ("off-target") cell types, such as platelets [19] [20] [21] and inflammatory cells 22, 23 that may cause detrimental body responses to the implanted scaffolds, is urgently needed for tissue engineering applications.
In the process of vascular development and regeneration, interactions between integrins, a family of heterodimeric receptors present on the cell surface, and their ligands in the ECM play important roles in vascular adhesion, migration, proliferation, survival and differentiation 24, 25 .
Previous reports showed that sixteen integrins are involved in vascular biology, and eight of them are expressed on EPCs/ECs (α1β1, α2β1, α3β1, α4β1, α5β1, α6β1, αvβ3, and αvβ5) at varying times 26, 27 . Thus, ligands that bind to integrins expressed on EPCs/ECs represent a good candidate for creating a bioactive interface to improve EPC/EC attachment and vascularization.
For example, arginine-glycine aspartic acid (RGD) motif is the most common integrin-binding sequence found within many ECM proteins and disintegrins [28] [29] [30] [31] [32] . However, the conventional, native RGD sequences, such as GRGD, are not specific and can be recognized by different integrins 33 . Therefore there is a critical need to identify novel ligands to target specific integrins with high binding specificity and affinity for EPCs/ECs. One-Bead-One-Compound (OBOC) combinatorial technology is an ultra-high throughput chemical library synthesis and screening method suitable for ligand discovery against a wide range of biological targets, such as integrins 34 . Previously, we applied OBOC combinatorial library method to discover cell attachment molecules and identified three potent ligands, LXY30, LXW7 and LLP2A, targeting integrin α3β1, αvβ3 and α4β1, respectively [35] [36] [37] . All of these three integrins are highly expressed on the surface of EPCs/ECs. In this study, to develop an optimal ligand with specific and high binding affinity to EPCs/ECs, we evaluated the interaction of these peptides with primary EPCs/ECs from different sources, platelets and monocytes; we found that LXW7 possessed the highest binding specificity to EPCs/ECs. ECs bound to LXW7 treated culture surface exhibited enhanced biological functions such as proliferation, likely due to increased phosphorylation of VEGF receptor 2 (VEGF-R2) and activation of mitogen-activated protein kinase (MAPK) ERK1/2. We further established a protocol to immobilize LXW7 on the surface of biomaterial scaffolds via Click chemistry and proved the stability and functionality of LXW7 presented on the biomaterial surface. This study, for the first time, describes novel EPC/EC targeting bioactive ligands discovered by OBOC combinatorial library technology for tissue regeneration applications. The novel ligand LXW7 holds great promise to facilitate EPC/EC attachment and function for improved endothelialization and vascularization of engineered tissue constructs.
RESULTS

Binding affinity of integrin-targeting peptide ligands with EPCs/ECs determined with on-
bead whole cell binding assay. a3β1, a4b1 and avβ3 are functionally important integrins expressed on EPCs/ECs 26 . Three integrin-targeting ligands LXY30 (a3β1), LLP2A (a4b1) and LXW7 (avβ3) identified previously by OBOC combinatorial library method [35] [36] [37] were tested for their binding activities to EPCs/ECs. THP-1 monocytes play important roles in inflammation in injured area also express a4b1 integrin 38 . After 2 h incubation, the results showed that LXY30 6 bound only to HCAECs ( Figure 1A, d ), but not to HECFCs or to THP-1 monocytes ( Figure 1A , a and g). LLP2A bound to both HECFCs and THP-1 monocytes ( Figure 1A , b and h), but not to HCAECs ( Figure 1A , e). LXW7 bound both HECFCs and HCAECs ( Figure 1A , c and f), but not to THP-1 monocytes ( Figure 1A , i). Quantification of the number of cells bound on each bead showed that there were significant differences between different types of cells bound on each bead modified with different types of ligands ( Figure 1B ). LXY30 only bound to ECs, not to EPCs. LLP2A only bound to EPCs, not to ECs. LXW7 bound to both EPCs and ECs well. Based on these results, we determined LXW7 as the optimal candidate ligand and LXW7 was further characterized in the following experiments. HECFCs (a-c), HCAECs (d-f) and THP-1 monocytes (g-i) were incubated with resin beads displaying LXY30 (left panels), LLP2A (middle panels) and LXW7 (right panels). Scale bar =50 μm. (B) The number of cells bound on beads displaying different types of ligands were quantified and statistical analyses were performed. Data were expressed as mean ± standard deviation: **p < 0.01 (n = 3).
Binding specificity of LXW7 to EPCs/ECs. Ligands with high binding specificity to
EPCs/ECs not only support the rapid cell attachment, but also potentially resist the attachment of other "off-target" cells, platelets and proteins. To confirm binding specificity of LXW7 to EPCs/ECs, resin beads displaying LXW7 were incubated with EPCs/ECs from different sources (HECFCs, HCAECs and HMVECs), THP-1 monocytes and platelets. At different time points after incubation (10 min, 30 min or 2 h), phase contrast images were taken to determine cell-bead binding affinity. We found that LXW7 efficiently supported attachment of EPCs/ECs from different sources and the number of cells attached to LXW7 beads increased over time ( Figure   2A , a-i). Remarkably, LXW7 did not support effective attachment of THP-1 monocytes ( Figure   2A , j-l) or platelets (Figure 2A , m-o). Quantification of the number of cells/ platelets bound on each bead showed that there were significantly more EPCs/ECs from different sources (HECFCs, HCAECs and HMVECs) compared to THP-1 monocytes and platelets on beads displaying LXW7 ( Figure 2B ). The results demonstrated that LXW7 possessed strong binding specificity to EPCs/ECs. Data were expressed as mean ± standard deviation: *p < 0.05, **p < 0.01 (n = 3).
Comparison of LXW7 with conventional RGD peptide on EPC/EC binding specificity
and affinity. Conventional tri-amino acid sequence, arginine-glycine-aspartate, or "RGD" has been widely used as an adhesive peptide in the biomaterials field to improve cell attachment.
However, conventional RGD binds to various types of cells and does not have high binding specificity to EPCs/ECs [39] [40] [41] . To investigate whether LXW7 possess higher specificity to EPCs/ECs, we compared EC binding specificity and affinity of LXW7 with conventional GRGD peptide by flow cytometry. The results showed that LXW7 had higher binding affinity with different types of EPCs/ECs than conventional GRGD peptide ( Figure 3C -E). Consistent with our previous results, both ligands did not bind to THP-1 monocytes ( Figure 3F ), and LXW7 had very low binding affinity with platelets but GRGD showed strong binding to platelets ( Figure   3G ). αvβ3 integrin is the major integrin expressed on EPC/EC 26, 27 , and aIIbβ3 integrin is restricted to cells of the megakaryocyte lineage, such as platelet causes thrombosis in circulation 42, 43 . Therefore, to further investigate the binding selectivity of LXW7 and conventional GRGD peptide, we used αvβ3-K562 cells highly expressed αvβ3 integrin and aIIbβ3-K562 cells highly expressed aIIbβ3 integrin as the probe cells to test the binding affinity of LXW7 and GRGD. We found that LXW7 had higher binding affinity than GRGD, although both GRGD and LXW7 bound well to avβ3-K562 cells ( Figure 3H ). On the other hand, LXW7 showed very low binding to αIIbβ3-K562 cells whereas GRGD showed very strong binding ( Figure 3I ). These results demonstrated that LXW7 possessed higher binding affinity to αvβ3 integrin but lower binding affinity to aIIbβ3 integrin than conventional RGD peptide, indicating that LXW7 has higher binding selectivity and superior potential than the conventional RGD peptide with respect to support stronger and more specific EPC/EC binding. To confirm the results from the flow cytometry analysis, we employed live cell culture assays to determine cell-ligand binding affinity. We used LXW7-bio or GRGD-bio (D-biotin as the negative control) to treat the culture surfaces and investigated selective attachment of HCAECs, THP-1 monocytes and platelets on culture surfaces. HCAECs bound to both LXW7 and GRGD treated surfaces within 10 min ( Figure 4A , d and g) but not to the control surface ( Figure 4A , a).
The number of attached cells were quantified and showed that LXW7 treated surface attracted more HCAECs than the GRGD-modified surface ( Figure 4B ), further confirming that LXW7 outperforms GRGD in regards to binding with ECs. Additionally, both LXW7 and GRGD treated surfaces did not support THP-1 monocyte attachment similar to the control surface ( Figure 4A , b, e and h and Figure 4B ). Furthermore, LXW7 treated surface showed limited platelet adhesion whereas GRGD treated surface allowed a significantly higher number of platelets to attach ( Figure 4A , f and i and Figure 4B ). This further confirmed our previous results that LXW7 supported stronger EC attachment but significantly weaker platelet attachment than conventional GRGD peptide. 
LXW7 binds to EPCs and ECs via avb3 integrin. avb3 integrin is highly expressed on
EPCs and ECs 26, 27 . To further confirm that LXW7 binds to EPCs/ECs mainly via avb3 integrin, we performed a binding/blocking experiment using a monoclonal anti-avb3 integrin antibody.
The results showed avb3 integrin was highly expressed on HECFCs ( Figure 5A 
Effects of LXW7 on EC biological functions.
We confirmed that LXW7 supported effective EC attachment. To determine whether LXW7 has any effects on other biological functions of ECs, we tested the effects of LXW7 on key functions of vascularization. The effect of LXW7 on EC proliferation was tested by MTS assay at different time points. Results showed that LXW7 treated surface significantly promoted EC proliferation after 48 h in culture compared with the D-biotin treated surface (control), and this trend was maintained for the entire period of the experiment ( Figure 6A ). We also tested whether the EPC/EC proliferation will be changed after LXW7 removal. EPCs (HECFCs) and ECs (HCAECs) were first cultured on surface modified with or without LXW7 for 4 days, and then cells were lifted and 3×10 3 viable cells were seeded per well in regular 96-well plates and cultured in EGM-2 media for 5 days. MTS assay was performed at each day and analyzed. The results showed that the proliferation of EPCs and ECs that were temporarily cultured on LXW7 modified surface did not change after LXW7 removal ( Figure S2 and Figure S3 ). These results indicated that persistent LXW7 existence was necessary to maintain the relevant bioactivities of EPCs/ECs, such as proliferation. ECs cultured on LXW7 treated surface for 96 h were collected for Western-blot analysis. Compared with the D-biotin treated surface (control), LXW7 treated surface significantly increased the phosphorylation of VEGFR2 (Tyr1175) and phosphorylation of its downstream signaling molecule ERK1/2 in ECs ( Figure 6B ). Our results were consistent with previous studies showing that activation of integrin avβ3 increased phosphorylation of VEGFR2 and ERK1/2 and promoted EC proliferation 44, 45 .
LXW7 induced EC proliferation may be attributed to the fact that LXW7 activated αvβ3 integrin and therefore enhanced phosphorylation of VEGFR2 and ERK1/2 and induced EC proliferation.
On the other hand, integrins have also been demonstrated to play a role in stem cell differentiation 46 . Notch signaling pathway has been shown to promote vascular maturation 47 , even by inducing integrin-mediated cell adhesion to the endothelial basement membrane 48 . We further tested the effect of LXW7 on the expression of immature and mature endothelial markers and Notch signaling pathway genes. The qPCR results showed no significant difference in the expression of these genes ( Figure S4 and Figure S5 ), indicating that LXW7 did not change the expression of endothelial markers and Notch signaling pathway genes in EPCs/ECs. Biomaterial scaffold surface modified with LXW7 supported EC attachment and spreading. ECM provides a three-dimensional structure and native ligands for cell attachment and tissue growth and functions 49 . To mimic ECM structure, we employed electrospinning technology to produce microfibrous scaffolds using PLLA and PCL polymer blends. SEM images showed that the electrospun scaffolds had a porous structure of microfibers ( Figure 7A ), similar in morphology to the native ECM. These scaffolds have a disadvantage over the ECM in that they lack bioactive motifs such as the integrin ligands that are normally present on the ECM and hence modification of the artificial ECM with functional ligands could improve its biological functions. Our prior results have suggested that LXW7, an artificial ligand targeting avβ3
integrin that can bind specifically to EPCs/ECs and activate EC biological functions, would be a good choice to modify the biomaterial scaffold surface. To improve biological functions of the microfibrous scaffolds, we developed a protocol to functionalize polymer surface by LXW7 via Click chemistry ( Figure 7C ). LXW7 was first functionalized with an azide group ( Figure 7B ). Microfibrous membranes were functionalized by covalently attaching H2N-PEG-alkyne to the carboxylic groups on the microfibers using EDC and Sulfo-NHS ( Figure 7C ). LXW-N3 was then attached to H2N-PEG-alkyne functionalized microfibers by Click chemistry ( Figure 7C ). ATR-FTIR spectrum analysis which has been proven to be a powerful tool for detecting amide bonds on solid surfaces 50 was used in this study to determine the immobilization of LXW7 on the scaffold surface. The ATR-FTIR spectra of the untreated and modified surfaces are shown in Figure 7D . The typical spectrum of the membranes modified with PEG-LXW7 was represented by an obvious rise in the intensity of the peak attributed to the amide I groups (1647 cm -1 ), which were distributed in a large number in the structure of LXW7-N3 ( Figure 7B ). The spectrum of the membranes modified by PEG only showed only a small evolution around 1630 cm -1 and 1670 cm -1 compared to the spectrum of the untreated membrane, because only a few amide I groups were formed after the membranes were modified with PEG linker only ( Figure 7C ). There was a significant difference between the spectra of PEG-LXW7 and PEG only modified membranes at 1647 cm -1 indicating that a large amount of amide I groups were introduced onto the membrane after LXW7 was modified ( Figure 7D ). All these data confirmed that LXW7 had been successfully immobilized on the membrane surface. adhered to LXW7-modified membranes compared to untreated membranes ( Figure 8B ).
HCAECs adhered on the membrane surfaces at 2 h were kept in culture for two days. SEM analysis showed that ECs grew and spread much better on LXW7-modified membrane ( Figure   8C , b and d) compared to the untreated membrane ( Figure 8C, a and c) . Quantification of cellcovered area showed that there was significantly more cell-covered area on LXW7-modified membranes compared to untreated membranes ( Figure 8D ). These results demonstrated that the function of LXW7 was well maintained after chemical modification and LXW7-modified biomaterials supported excellent attachment and spreading of ECs. 
DISCUSSION
Tissue engineering, a fast growing field in regenerative medicine, has significant prominence over the past three decades 51 . Vascularization is critically central to tissue development, maintenance and regeneration 52 . EPCs and ECs from different sources, e.g., from circulation and from local tissues, play crucial roles in the process of vascularization 53, 54 . In addition, bioactive coating or modification of biomaterial scaffolds hold the promise of improving tissue regeneration by stimulating the formation of necessary blood vessels required for the short-term tissue regeneration and long-term tissue survival and function 55 . Therefore, an ideal bioactive coating molecule that specifically targets EPCs/ECs can be used for biomaterial engineering to achieve functional and meaningful tissue regeneration. Several important aspects need to be taken into account for choosing bioactive molecules: (1) having high binding specificity to EPCs/ECs, not to other undesirable cell types to improve endothelialization and vascularization, to reduce inflammation and to prevent thrombosis, (2) displaying all high-extended bioactive functionality after modification to ECs, and (3) possessing good stability and low degradation in the body.
The understanding of the intricate interactions between cells and their microenvironment ECM in tissues has been much improved in the past decades. Based on the basic biology understanding, more attention in the field of tissue engineering has been focused on the designing of optimal scaffolds that can imitate the componential and structural aspects of ECM to facilitate cell recruiting/seeding, adhesion, proliferation, differentiation, and neotissue genesis [56] [57] [58] .
From a structural perspective, natural ECM consists of various interwoven protein fibers with diameters ranging from nanometers to micrometers. The nano/micro scale structure of ECM offers a natural network of nanofibers to support and guide cell behavior and function.
Developing scaffolds that imitate the architecture of ECM is an effective approach to improve the functionality of the scaffolds. Electrospinning technique is a powerful tool to make nano/microfibrous scaffolds that imitate the native tissue architecture, and allow the integration of the grafts/scaffolds with surrounding cells and promote tissue regeneration. We have successfully used electrospinning techniques to fabricate microfibrous scaffolds for various tissue regeneration applications such as for peripheral nerve regeneration 59, 60 , spinal cord regeneration [61] [62] [63] [64] , vascular tissue regeneration 15 , drug delivery 65 , and wound healing 66 .
From a componential perspective, natural ECM consists of a wide variety of biomolecules that provide critical biological binding sites for the cells to function in a specific way. Ordinary electrospun microfibrous scaffolds have the three-dimensional structure imitating the native ECM architecture but lack bioactive molecules on the surface. Therefor their functionalities can be further improved by modifying their surface with bioactive ligands.
OBOC combinatorial library method is a powerful tool to identify ligands with high specificity and affinity to a desired cell type. It is known that RGD can be recognized by more than 20 integrins including avb3 and aIIbb3, and the binding specificity of different RGD-containing peptides to different integrins depends on the conformation structure of the RGD motif and the adjacent amino acids of the ligand 67 . The OBOC library can be designed based on the main triad motif flanking with random amino acids leading to the discovery of specific ligands with higher affinity and selectivity towards targeted cells. In addition, non-natural amino acids and disulfide bonds with D-cysteines are chosen to synthesize the ligands that confer higher stability for the ligands 36 . In recent years, we have used this technology and identified several important ligands targeting different cell surface integrin receptors 35, 37, 68, 69 . αvβ3 integrin is highly expressed on angiogenic ECs and EPCs, and hence ligands specifically targeting the αvβ3 integrin would have significant application for tissue engineering and regeneration where EC behavior and functions are critically needed.
Previously, we confirmed that LXW7, a peptide discovered by screening OBOC libraries, had high binding affinity to avb3 integrin (Kd = 76±10 nM, IC50 = 0.68±0.08 μM) 36 . In the present study, we further investigated the binding specificity and functionality of LXW7 to EPCs and ECs. Conventional RGD-containing peptides derived from native ECM sequences have been reported to bind to avb3 integrin 36, 40 , but they had low binding specificity to EPCs/ECs 70 . Our data in the present study showed that LXW7 exhibited higher binding affinity to EPCs and ECs isolated from various sources compared with the conventional GRGD sequence. More importantly, we found that LXW7 did not bind to monocytes and showed very low binding affinity to platelets. Monocytes can be attracted and accumulate at sites of inflammation and infections and cause detrimental body responses such as forming early plaques in vascular diseases by differentiating into foam cells 71 . It is known that b1 integrins, especially a4b1, are highly expressed on monocytes and mainly responsible for extracellular matrix protein binding in monocytes, but b3 integrins are not expressed on monocytes 72, 73 , and these may explain why LXW7 does not bind to monocytes. Platelets easily aggregate in blood and deposit on the vascular bed and secrete numerous proteins that promote attachment of the other cells that carry deleterious risk of thrombus formation. Therefore, the adhesion and activation of platelets and inflammatory cells on the material surface is often used to evaluate a material's thrombogenicity 21, [74] [75] [76] . It is known that the adhesion and aggregation of platelets are mediated by αIIbβ3 integrin rather than αvβ3 integrin 42 and this explains why LXW7 showed very low binding affinity to platelets. These indicate that LXW7 might be a better ligand for EPC/EC recruitment and delivery applications. From the antibody binding/blocking experiments, we confirmed the interaction between LXW7 and EPCs/ECs is mainly mediated by avb3 integrin. We also noted that the binding of LXW7 to EPCs/ECs was not completely blocked by anti-avb3 integrin antibody, probably due to the size difference between LXW7 (a short peptide of 8 amino acids) and anti-avb3 integrin antibody which is a large biomacromolecule. LXW7 also improved EC proliferation and increased phosphorylation of VEGFR2 and ERK1/2 in ECs. This is consistent with the results in the previous studies about the interaction between avb3 integrin and VEGFR2 and ERK1/2 in ECs 44, 45, 77 . Although LXW7 was originally discovered through screening a focused cyclic RGD library with engineered myeloid leukemia K562 cells, we can easily use EPCs/ECs as probes to screen similar libraries. Furthermore, in addition to just screening for cell binding, we can easily screen for both binding and cell signaling such as ERK1/2 activation. The latter can be achieved via staining the bound cells with anti-phospho-ERK1/2 antibody followed by secondary antibody-horse radish peroxidase and colorimetric substrate.
From another crucial angle, addition of tool molecules, such as biotin, to ligands will be advantageous to be used in combination with other components and to expand the ligand's bioengineering applications. Our previous study has shown that biotinylation of LXW7 did not decrease its binding affinity and showed nearly identical binding strength to αvβ3 integrin 36 , whereas biotinylation of commonly used pentapeptides, such as cyclo(RGDfE), cyclo(RGDfK), and cyclo(RGDyK) lead to a 2-to 8-fold decrease in the affinity strength to αvβ3 integrin 36 . In this study, we designed LXW7-N3, and utilized Click chemistry to immobilize LXW7-N3 on electrospun microfibrous PLLA/PCL membrane surface. In order to minimize the effect of the linker to the ligand binding and increase its water solubility, two units of PEG-like short linker (Ebes) were inserted between the C-terminus of ligand and Lys (biotin) as well as Click conjugation site (N3). We have successfully used the same linker strategy in many of our previously ligand-conjugates 78, 79 . LXW7 modified surface significantly increased the binding of ECs to the scaffold surface and improved endothelial coverage on the material surface. LXW7 is a potent ligand for surface modification of tissue engineered biomaterial constructs to improve endothelial coverage and vascularization in the scaffolds. We plan on utilizing this approach for in vitro EC expansion and in vivo delivery, for 3D biomaterial scaffold surface modification to improve in situ EC recruitment, endothelialization and vascularization. We also plan on testing the in vivo efficacy of LXW7 to modify vascular grafts to improve endothelialization for blood vessel regeneration.
CONCLUSION
In this study, we discovered that a novel avb3 integrin ligand LXW7 can potential be widely used for tissue engineering applications. Unlike the traditional integrin αvβ3 ligand GRGD peptide, LXW7 showed highly specific and strong interaction with EPCs/ECs but did not bind to monocytes and had very low binding affinity to platelets. Therefore, LXW7 can be used as an excellent EC specific ligand to improve EC biological functions while preventing platelet and inflammatory cell adhesion. LXW7 is a cyclic peptide containing natural and non-natural amino acids, therefore it will be more resistant to proteolysis and more stable in vivo compared to linear peptides only consisting of natural amino acids. Furthermore, LXW7 can be used as an excellent lead ligand for further optimization by using high throughput OBOC focused combinatorial library to develop more potent and specific small bioactive ligands that could be used in the future for more specific tissue regeneration applications.
MATERIALS AND METHODS
Cell culture and platelet isolation. Endothelial colony forming cells (ECFCs), also often referred to as outgrowth endothelial cells (OECs), which are a subtype of EPCs, can be identified from circulating human adult peripheral blood and umbilical cord blood 80 . In this study, the ECFCs were isolated from human umbilical cord blood as previously described 80, 81 . Human umbilical cord blood (10 U heparin/mL blood) was obtained from the UC Davis Umbilical Cord Blood Collection Program (UCBCP) and diluted 1:1 with phosphate-buffered saline (PBS), without calcium and magnesium, pH 7.2 (Hyclone). Fifteen mL Ficoll-Paque PLUS (Amersham Biosciences) was laid at the bottom of 20 mL diluted blood and centrifuged at 2000 rpm for 30
minutes at room temperature. The hazy layer of mononuclear cells (MNCs) at the interface between the Ficoll and serum was collected and dispensed into 50-mL conical tube containing 10 mL EBM-2 (Lonza) and centrifuged at 1500 rpm for 10 min at room temperature. The supernatant was carefully aspirated and the pellets were treated with red blood cell lysis buffer (eBioscience, Inc.) and then sorted by CD34 microbead magnetic sorting (Miltenyi Biotec GmbH) as per manufacturer's instructions. The CD34 + cells were seeded on rat-tail collagen I (BD Biosciences Discovery) coated tissue culture plates and cultured in EGM-2 media (Lonza).
After 24 h, non-adherent cells were removed and the media was changed daily to day 7 and every other day thereafter. ECFC-derived colonies appeared between day 4 and day 7 of culture with typical endothelial cobblestone pattern. Individual colonies were isolated and expanded and allowed to grow to 80% to 90% confluency before first passage. ECFCs were used between P3 and P5 for all experiments. Human coronary artery endothelial cells (HCAECs) were purchased from ATCC. Human cardiac microvascular endothelial cells (HMVECs) were purchased from Lonza. THP-1 monocytes were obtained from Dr. Pamela Lein (University of California, Davis).
The myeloid leukemia K562 cells that have been transfected with human integrin αvβ3 gene 
Synthesis and screening of OBOC Peptide Libraries.
In our previous studies, we synthesized and screened several random linear and cyclic OBOC peptide libraries using a cellgrowth-on-bead assay and identified three potent ligands LXY30, LXW7 and LLP2A targeting integrin α3β1, αvβ3 and α4β1 [35] [36] [37] , respectively. All of these integrins are highly expressed on the surface of EPCs/ECs. In this study, we synthesized LXY30, LXW7 and LLP2A on TentaGel resin beads and used them as a convenient platform for cell-bead and platelet-bead binding assays to investigate the ligand-cell/platelet binding affinity and specificity.
EPC/EC-bead, monocyte-bead and platelet-bead binding assay. HECFCs, HCAECs, HMVECs and THP-1 monocytes were cultured in their respective growth medium described above. For cell bead-binding assay, 6×10 5 HECFCs, HCAECs, HMVECs or THP-1 monocytes in 2 mL of their respective culture medium were added to an ultra-low attachment 35-mm Petri dish (Corning Incorporated) followed by resin beads 34 . The dishes were incubated in a shaking incubator at 37 °C, 5% CO2 for various time points at 40 rpm. For platelet-bead binding assay, the platelets isolated as described above were added to an ultra-low attachment 35-mm Petri dish and incubated with the resin beads in the shaking incubator as described for the cell-bead binding assay. Phase contrast images were taken at different time points using Olympus IX81microscope.
Flow cytometry analysis of ligand-cell binding affinity. We synthesized biotinylated LXW7
(LXW7-bio, Figure 3A ) and biotinylated GRGD (GRGD-bio, Figure 3B EC, monocyte and platelet attachment assay. To modify culture surface with ligands, target culture wells in a 24-well plate were coated with 500 μL of 20 μg/mL Avidin (Thermo Fisher Scientific), and incubated for 1 h at 37°C. Avidin coated wells were rinsed three times with DPBS and were treated with 500 μL molar equivalents (2 μM) of D-biotin (Thermo Fisher Scientific), LXW7-bio, or GRGD-bio. After 1 h, the wells were washed three times with DPBS and blocked with 1% BSA (Thermo Fisher Scientific) for 1 h. After the wells were rinsed three times with DPBS, for cell attachment assay, 5×10 4 HCAECs and THP-1 monocytes suspended in the respective maintenance medium were added to the wells and incubated for 10 min or 16 h at 37°C, 5% CO2, respectively. After each time point the wells were washed three times with DPBS, and the adhered cells were fixed in 10% formalin (Azer Scientific) for 20 min. For platelet attachment assay, the PRP was centrifuged, and the platelet pellet was resuspended in 1% BSA with 2 mM CaCl2 and 1 mM MgCl2 to achieve a final concentration of 1×10 8 platelets/mL and added to the wells at a density of 5×10 7 platelets /cm 2 and incubated for 16 h at 37°C, 5% CO2.
The wells were washed three times with DPBS, and the adhered platelets were fixed in 10% formalin for 20 min. For evaluation of HCAEC attachment, the HCAEC wells were washed with DPBS again and blocked for 1 h with 1% BSA. An additional wash was performed, and the plate was incubated overnight with mouse anti-CD31 antibody (1:100; Abcam) in 1% BSA at 4°C.
The wells were washed and incubated with goat anti-mouse Alexa Fluor 594 conjugate (1:500;
Life Technologies) in 1% BSA for 1h at room temperature and then nuclei were stained with DAPI. After three times of washing with DPBS, the HCAECs were imaged using an Olympus IX81 microscope. Phase contrast images were taken using Olympus IX81microscope for evaluation of THP-1 monocyte and platelet attachment. Quantification of images was performed using the Image J software (NIH).
MTS assay of EC proliferation on LXW7. The 96-well plates were treated with 1 μM
Avidin solution for 1 h at room temperature. Avidin coated wells were rinsed three times with DPBS and treated with LXW7-bio (1 μM), with D-biotin (1 μM) serving as the control. After 1 h, the wells were washed three times with DPBS and blocked with 1% BSA for 1 h. 3×10 3 viable HCAECs were seeded per well and cultured in EGM-2 media for 5 days. To test whether the EPC/EC proliferation will be changed after LXW7 removal, we first cultured EPCs (HECFCs) and ECs (HCAECs) on culture surface modified with or without LXW7 for 4 days. Then, EPCs/ECs were lifted from culture surface modified with or without LXW7 and 3×10 3 viable cells were seeded per well in 96-well plates and cultured in EGM-2 media for 5 days. MTS assay was performed at each day as per the manufacturer instructions (Interchim) and analyzed on SpectraMax-3 plate reader (Molecular Devices).
Western-blot analysis. 100-mm dishes were first treated with Avidin followed by LXW7-bio or D-biotin as described above. Real-time quantitative RT-PCR (RT-qPCR). 60-mm dishes were first treated with Avidin followed by LXW7-bio or D-biotin as described above. Table S1 .
Preparation of LXW7 modified biomaterial scaffolds. Fabrication of electrospun microfibrous biomaterial scaffolds was performed as previously reported 15, 59, 60 . Poly (L-lactic acid) (PLLA) (MW 67,400, Sigma Aldrich) and polycaprolactone (PCL, MW 2,000, Polysciences) were used to fabricate the microfibrous membranes. The polymer blends (e.g., 19% PLLA and 5% PCL; w/v) were completely dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP, Aladdin). Microfibrous membranes with thickness of about 200 µm were prepared by electrospinning polymer fibers onto to the rotating drum collector. The negative voltage of 4.5 kV was applied to the mandrel, and a positive voltage of 4 kV was applied to the spinneret by using a high voltage generator (Gamma High Voltage).
LXW7 was grafted onto PLLA/PCL membrane surface through three steps. First, membranes were incubated in 0.01 M Sodium Hydroxide for 10 min to expose the carboxyl groups on the surface. Second, the membranes were further incubated in solution of 1-ethyl-3-(3dimethylaminopropyl) carbodiimide hydrochloride (EDC) and N-hydroxysulfosuccinimide (sulfo-NHS) (Thermo Fisher Scientific) in 0.5 M morpholino ethane sulfonic acid (MES) buffer (pH 5.5, Thermo Fisher Scientific) for 30 min. After brief washing with DPBS, the membranes were incubated in a solution of H2N-PEG-alkyne (MP 5000, Polysciences, Inc.) in DPBS for 2 h on shaker. Lastly, 100 nM azido derivatized LXW7 (LXW7-N3) ( Figure 7B ), synthesized via a similar approach as LXW7-bio but with a 5-azidopentanoic acid attached to the side chain of lysine (Supporting Information Figure S1 ), was conjugated to alkyne-decorated membranes via Click chemistry in the presence of 5 μM CuSO4·5H2O, 50 μM sodium ascorbate, Cu powder, and N,N-Diisopropylethylamine (DIEA) (all from Sigma) in water system for 6 d 82 .
The structure of the membranes was characterized with a scanning electron microscope (SEM, Hitachi TM-1000). Attenuated total reflection spectra of the untreated, PEG only modified, and PEG-LXW7 modified membranes were obtained using an Attenuated Total Reflectance-Fourier transform infrared (ATR-FTIR) spectrometer (PerkinElmer).
Biomaterial scaffold modified with LXW7 supported EC attachment and spreading.
LXW7 modified electrospun microfibrous membranes and untreated control membranes were placed in 35 mm tissue culture dishes. The membranes were rinsed with DPBS and incubated with HCAECs in EGM-2 media at a density of 5×10 4 cells/cm 2 . After 2 h incubation, the media was aspirated, and unattached cells were washed off with DPBS three times. The adhered cells were fixed in 10% formalin and incubated overnight with mouse anti-CD31 antibody (1:100; Abcam) at 4°C. After washed, the adhered cells were incubated with goat anti-mouse Alexa Fluor 594 conjugate (1:500; Life Technologies) for 1 h at room temperature and then nuclei were stained with DAPI. After three times of washing with DPBS, the cells were imaged using an Olympus IX81 microscope. Some of the cell samples were further cultured in EGM-2 media for 2 d and cell morphology and spreading on the microfibrous scaffold surface were characterized with SEM. The cell-covered area was quantified using Image J software. 
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